CW, H., CC, C., SC, C., YY, C., BW, L., HH, C., . . . JY, W. (2025). Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: A nationwide real-world study. American journal of cancer research, 15(7), 3093. https://doi.org/10.62347/QZFD8646
Chicago Style (17th ed.) CitationCW, Huang, et al. "Efficacy and Safety of First-line Cetuximab Therapy for Older Patients (aged ≥ 70 Years) with RAS Wild-type Metastatic Colorectal Cancer: A Nationwide Real-world Study." American Journal of Cancer Research 15, no. 7 (2025): 3093. https://doi.org/10.62347/QZFD8646.
MLA (9th ed.) CitationCW, Huang, et al. "Efficacy and Safety of First-line Cetuximab Therapy for Older Patients (aged ≥ 70 Years) with RAS Wild-type Metastatic Colorectal Cancer: A Nationwide Real-world Study." American Journal of Cancer Research, vol. 15, no. 7, 2025, p. 3093, https://doi.org/10.62347/QZFD8646.
